Nomogram for predicting survival in patients with advanced hepatocellular carcinoma treated with PD-1 inhibitors: incorporating pre-treatment and post-treatment clinical parameters

BACKGROUND: Immunotherapy has transformed cancer treatment patterns for advanced hepatocellular carcinoma (aHCC) in recent years. Therefore, the identification of predictive biomarkers has important clinical implications. METHODS: We collected medical records from 117 aHCC patients treated with anti...

Descripción completa

Detalles Bibliográficos
Autores principales: Jia, Guhe, Qiu, Lupeng, Zheng, Hongye, Qin, Boyu, Sun, Zhuoya, Shao, Yangyang, Yang, Zizhong, Shao, Jiakang, Zhou, Yuxin, Jiao, Shunchang
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2023
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10273750/
https://www.ncbi.nlm.nih.gov/pubmed/37328805
http://dx.doi.org/10.1186/s12885-023-11064-1

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10273750/
https://www.ncbi.nlm.nih.gov/pubmed/37328805
http://dx.doi.org/10.1186/s12885-023-11064-1

Ejemplares similares